Natco Pharma Ltd. | Mid-cap | Healthcare
₹872.05
-0.35%
| Natco Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 44.3B
Gross Profit 37.4B 84.43%
Operating Income 19.6B 44.27%
Net Income 18.8B 42.52%

Balance Sheet Metrics

Total Assets 86.3B
Total Liabilities 10.2B
Shareholders Equity 76.1B
Debt to Equity 0.13

Cash Flow Metrics

Operating Cash Flow 19.3B
Free Cash Flow 11.9B

Revenue & Profitability Trend

Natco Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 44.3B 39.8B 27.0B 19.0B 16.9B
Cost of Goods Sold 6.9B 8.6B 7.5B 6.8B 6.1B
Gross Profit 37.4B 31.2B 19.5B 12.2B 10.8B
Operating Expenses 9.5B 8.4B 5.2B 5.3B 4.1B
Operating Income 19.6B 15.8B 7.9B 1.4B 5.0B
Pre-tax Income 22.9B 16.7B 8.6B 2.0B 5.8B
Income Tax 4.1B 2.9B 1.5B 322.0M 1.4B
Net Income 18.8B 13.9B 7.2B 1.7B 4.4B
EPS (Diluted) - ₹77.34 ₹39.18 ₹9.32 ₹24.16

Income Statement Trend

Natco Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 52.7B 40.2B 30.0B 24.9B 23.4B
Non-Current Assets 33.6B 28.8B 26.6B 26.2B 24.5B
Total Assets 86.3B 69.1B 56.6B 51.1B 48.0B
Liabilities
Current Liabilities 9.4B 9.7B 6.8B 7.1B 5.3B
Non-Current Liabilities 750.0M 804.0M 1.0B 1.4B 1.4B
Total Liabilities 10.2B 10.5B 7.8B 8.5B 6.7B
Equity
Total Shareholders Equity 76.1B 58.5B 48.7B 42.6B 41.2B

Balance Sheet Composition

Natco Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 22.9B 16.7B 8.6B 2.0B 5.8B
Operating Cash Flow 19.3B 12.4B 7.9B -582.0M 4.3B
Investing Activities
Capital Expenditures -3.1B -3.4B -1.2B -1.8B -2.1B
Investing Cash Flow -14.7B -10.7B -4.7B -458.0M -1.7B
Financing Activities
Dividends Paid -1.1B -1.7B -1.0B -822.0M -1.1B
Financing Cash Flow -1.9B -2.3B -3.5B 542.0M -2.2B
Free Cash Flow 11.9B 8.5B 6.4B -2.0B 442.0M

Cash Flow Trend

Natco Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 8.67
Forward P/E 22.12
Price to Book 2.15
Price to Sales 3.69
PEG Ratio 22.12

Profitability Ratios

Profit Margin 42.57%
Operating Margin 36.84%
Return on Equity 27.97%
Return on Assets 15.78%

Financial Health

Current Ratio 5.59
Debt to Equity 3.67
Beta 0.31

Per Share Data

EPS (TTM) ₹105.23
Book Value per Share ₹424.69
Revenue per Share ₹247.30

Financial data is updated regularly. All figures are in the company's reporting currency.